Device Trial Radar · NCT04415606
QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding
Last checked: Nov 20, 2026Latest source record: Apr 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
266
Actual
Start
Jun 11, 2020
Primary completion
Oct 30, 2021
Study completion Oct 30, 2021
Sponsor
- Lead sponsor
- Z-MedicaNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 4, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
QuikClot Control+ Hemostatic Dressing (QuikClot+) is indicated for temporary control of internal organ space bleeding for patients displaying Class III or Class IV Bleeding. It may also be used for control of severely bleeding wounds such as surgical wounds and traumatic injuries. QuikClot Control+ is also indicated for temporary control of mild to moderate bleeding in cardiac surgical procedures. QuikClot Control+ is also indicated for use to control bleeding from bone surface following sternotomy.
Conditions
- Hemostasis
Interventions
QuikClot Control+Device
Non-absorbable, sterile, X-ray detectable non-woven dressing impregnated with kaolin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Achievement of hemostasisTime frame: Up to 10 minutes
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
University of Colorado Health
Aurora, Colorado
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.